These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8947998)

  • 21. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
    Pecknold JC
    J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzodiazepines in schizophrenia: a need for reassessment.
    Nestoros JN
    Int Pharmacopsychiatry; 1980; 15(3):171-9. PubMed ID: 6113219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy.
    Włodarczyk A; Szarmach J; Cubała WJ; Wiglusz MS
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):345-348. PubMed ID: 28953788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia.
    Caforio G; Di Giorgio A; Rampino A; Rizzo M; Romano R; Taurisano P; Fazio L; De Simeis G; Ursini G; Blasi G; Nardini M; Mancini M; Bertolino A
    J Clin Psychopharmacol; 2013 Dec; 33(6):810-2. PubMed ID: 24113675
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid tranquilization: antipsychotics or benzodiazepines?
    Dubin WR
    J Clin Psychiatry; 1988 Dec; 49 Suppl():5-12. PubMed ID: 2904430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepine augmentation of neuroleptic treatment in patients with schizophrenia.
    Pato CN; Wolkowitz OM; Rapaport M; Schulz SC; Pickar D
    Psychopharmacol Bull; 1989; 25(2):263-6. PubMed ID: 2574897
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjunctive medication in the maintenance treatment of schizophrenia and its conceptual implications.
    Siris SG
    Br J Psychiatry Suppl; 1993 Dec; (22):66-78. PubMed ID: 7906526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of benzodiazepines in psychiatry.
    Harangozó J; Magyar I; Faludy G
    Ther Hung; 1991; 39(3):103-11. PubMed ID: 1818422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodiazepines in the treatment of schizophrenia: an updated survey.
    Lingjaerde O
    Acta Psychiatr Scand; 1991 Nov; 84(5):453-9. PubMed ID: 1685616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of acute symptoms and compliance attitude in noncompliant patients with schizophrenia.
    Liu-Seifert H; Houston JP; Adams DH; Kinon BJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):392-4. PubMed ID: 17632224
    [No Abstract]   [Full Text] [Related]  

  • 31. Benzodiazepines as adjunctive therapy in treatment refractory symptoms of schizophrenia.
    Szarmach J; Włodarczyk A; Cubała WJ; Wiglusz MS
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):349-352. PubMed ID: 28953789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive findings for negative symptoms of schizophrenia: no longer untreatable?
    Stahl SM
    Acta Psychiatr Scand; 2006 Nov; 114(5):301-2. PubMed ID: 17022789
    [No Abstract]   [Full Text] [Related]  

  • 33. Polypharmacy in schizophrenia.
    Baandrup L
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):183-192. PubMed ID: 31908124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008.
    Tor PC; Ng TP; Yong KH; Sim K; Xiang YT; Wang CY; Lee EH; Fujii S; Yang SY; Chong MY; Ungvari GS; Si T; He YL; Chung EK; Chee KY; Trivedi J; Udomratn P; Shinfuku N; Kua EH; Tan CH; Sartorius N; Baldessarini RJ
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):735-45. PubMed ID: 21294941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the benzodiazepine derivative estazolam in schizophrenia.
    Astrup C; Vatten L
    Biol Psychiatry; 1984 Jan; 19(1):85-8. PubMed ID: 6142731
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjunctive benzodiazepines in acute schizophrenia.
    Cohen S; Khan A
    Neuropsychobiology; 1987; 18(1):9-12. PubMed ID: 2895435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacologic treatment of schizophrenia: a progress report.
    Donaldson SR; Gelenberg AJ; Baldessarini RJ
    Schizophr Bull; 1983; 9(4):504-27. PubMed ID: 6140750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing resistant schizophrenia.
    Huckle PL; Palia SS
    Br J Hosp Med; 1993 Oct 20-Nov 2; 50(8):467-71. PubMed ID: 7903897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of schizophrenia. The Expert Consensus Panel for Schizophrenia.
    J Clin Psychiatry; 1996; 57 Suppl 12B():3-58. PubMed ID: 8946807
    [No Abstract]   [Full Text] [Related]  

  • 40. Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.
    Fontanella CA; Campo JV; Phillips GS; Hiance-Steelesmith DL; Sweeney HA; Tam K; Lehrer D; Klein R; Hurst M
    J Clin Psychiatry; 2016 May; 77(5):661-7. PubMed ID: 27249075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.